David Boyer in Los Angeles, California

Home California Los Angeles

David Boyer has Ophthalmology as his primary medical specialty. Their primary office is: 1245 Wilshire Blvd in Los Angeles, California. There is an additional office location, for a total of two, for David Boyer that can be viewed further down.

They're a part of the: Retina Vitreous Associates Medical Group medical group which has around 12 members. You can call their office at 213-483-8810 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1972 (around 52 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David S Boyer Office Phone and Directions

David Boyer
Retina Vitreous Associates Medical Group
1245 Wilshire Blvd
Los Angeles, California 90017
213-483-8810

Patient Ratings
Please rate your experience with David Boyer below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 213-483-8810

Enter a starting address:

Healthcare Info for David Boyer

Medical School: Sorry, his university is not listed
Graduation Year: 1972
The Primary Medical Specialty for David Boyer is listed as: Ophthalmology
Approximate Years of Experience: 52
PAC (PECOS ID)#: 8527071273
NPI #: 1295736916
NPI Created On: 08/03/2005
NPI Last Updated Listed as: 01/23/2020
Primary Taxonomy Code: 207W00000X
License Number:
G25107
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Russian, Korean, Armenian.

Services and Procedures include:

Injection of drug into eye
Removal of membrane from the retina, pars plana approach
Laser destruction of retinal growth, 1 or more sessions
Laser destruction of leaking retinal blood vessels, 1 or more sessions
Ultrasound of eye tissue and structures
Ultrasound of eye disease, growth, or structure
Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
Eye and medical examination for diagnosis and treatment, established patient
Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
Diagnostic imaging of retina
Extended examination of eye with drawing of retina
Extended examination of eye with drawing of optic nerve and surrounding area (macula)
Imaging of blood vessels in back of eye using fluorescein dye
Photography of the retina
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient, visit typically 25 minutes
Injection, aflibercept, 1 mg
Injection, ranibizumab, 0.1 mg
Injection, triamcinolone acetonide, preservative free, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 799201859

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Chronic Non-infectious Posterior Segment Uveitis

Name of Drug #1: YUTIQ

Open Associated Drug #1: 71879-136-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 799200495

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Chronic Non-infectious Posterior Segment Uveitis

Name of Drug #1: YUTIQ

Open Associated Drug #1: 71879-136-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835903331

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology and Ophthalmology

Name of Drug #1: SUSVIMO

Open Associated Drug #1: 50242-078-12

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835903333

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01

Payments Total: $643

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 826530113

Being Disputed:: No

Product Related: No

Payments Total: $643

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 826530109

Being Disputed:: No

Product Related: No

Payments Total: $643

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 826530111

Being Disputed:: No

Product Related: No

Payments Total: $900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 815623269

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Ocular

Name of Drug #1: EYSUVIS

Open Associated Drug #1: 71571-333-83

Payments Total: $450

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 815623273

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Ocular

Name of Drug #1: EYSUVIS

Open Associated Drug #1: 71571-333-83

Payments Total: $3,240

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: David S. Boyer MD, Inc.

Third party is a Charity:: No

Record ID:: 809680629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02

Additional Office Locations

1. Retina Vitreous Associates Medical Group
9001 Wilshire Boulevard
Beverly Hills, CA 90211
Suite 301
Group Members: 12

Phone: 213-483-8810

Enter a starting address:

Ophthalmology Professionals in Los Angeles

1.
Sandeep Khanna

1700 E Cesar E Chavez Ave
Los-angeles, CA
Mercy Eye Care Medical Group Inc

2.
Sona Shah

1520 San Pablo St 1st Floor N
Los-angeles, CA
Usc Care Medical Group Inc

3.
Sona Shah

1520 San Pablo St
Los-angeles, CA
Usc Care Medical Group Inc

4.
Sona Shah

1500 San Pablo St
Los-angeles, CA
Usc Care Medical Group Inc

5.
Sona Shah

1516 San Pablo St
Los-angeles, CA
Usc Care Medical Group Inc

6.
Anthony Nesburn

8635 W 3rd St
Los-angeles, CA
American Eye Institute

Providers in Retina Vitreous Associates Medical Group

1.David Boyer

1245 Wilshire Blvd
Los Angeles Ca 90017-4886
Retina Vitreous Associates Medical Group
Ophthalmology

2.David Boyer

9001 Wilshire Boulevard
Beverly Hills Ca 90211-1841
Retina Vitreous Associates Medical Group
Ophthalmology

3.Thomas Chu

1245 Wilshire Blvd
Los Angeles Ca 90017-4886
Retina Vitreous Associates Medical Group
Ophthalmology

4.Thomas Chu

9001 Wilshire Boulevard
Beverly Hills Ca 90211-1841
Retina Vitreous Associates Medical Group
Ophthalmology

5.Thomas Chu

3400 Lomita Blvd
Torrance Ca 90505-4914
Retina Vitreous Associates Medical Group
Ophthalmology

6.Thomas Chu

301 S Fair Oaks Ave
Pasadena Ca 91105-2562
Retina Vitreous Associates Medical Group
Ophthalmology

View all 12 members of Retina Vitreous Associates Medical Group medical group